ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 6.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $103,397 | -57.3% | 44,664 | -17.5% | 0.00% | – |
Q1 2024 | $241,899 | +70.0% | 54,116 | +21.2% | 0.00% | – |
Q4 2023 | $142,255 | +180.4% | 44,664 | +176.5% | 0.00% | – |
Q3 2023 | $50,727 | -61.3% | 16,155 | +40.5% | 0.00% | – |
Q2 2022 | $131,000 | -49.8% | 11,500 | -59.5% | 0.00% | – |
Q1 2022 | $261,000 | +4.0% | 28,429 | +69.7% | 0.00% | – |
Q4 2021 | $251,000 | -64.0% | 16,749 | -38.1% | 0.00% | -100.0% |
Q3 2021 | $698,000 | -37.2% | 27,067 | -36.3% | 0.00% | 0.0% |
Q2 2021 | $1,111,000 | +173.6% | 42,460 | +269.2% | 0.00% | – |
Q1 2021 | $406,000 | +2.8% | 11,500 | -26.3% | 0.00% | -100.0% |
Q4 2020 | $395,000 | -37.7% | 15,610 | -6.9% | 0.00% | 0.0% |
Q3 2020 | $634,000 | +28.9% | 16,766 | +45.8% | 0.00% | 0.0% |
Q2 2020 | $492,000 | +100.8% | 11,500 | -11.1% | 0.00% | 0.0% |
Q1 2020 | $245,000 | – | 12,939 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |